Yuki Sato

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study

Shunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto et al. · Journal of Thoracic Oncology · 2017 · 368 citations · Full text

Oncology, Cancer Epidemiology, Cancer Management +9

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis

Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu et al. · Journal of Thoracic Oncology · 2020 · 96 citations · Full text

Translational Medicine, Antibiotics, Pretreated Nsclc +5

Success Rate of Gingivoperiosteoplasty with and without Secondary Bone Grafts Compared with Secondary Alveolar Bone Grafts Alone

Yuki Sato, Barry H. Grayson, Judah S. Garfinkle et al. · Plastic & Reconstructive Surgery · 2008 · 90 citations

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

Daichi Fujimoto, Keiichiro Uehara, Yuki Sato et al. · Scientific Reports · 2017 · 85 citations · Full text

Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)

Yoshihiko Sakata, Shinya Sakata, Yuko Oya et al. · European Journal of Cancer · 2021 · 81 citations

Real-world Setting, Medicine, Pathology +8